Navigation Links
METTLER TOLEDO and ThalesNano Bring Real-time Reaction Monitoring to Flow Synthesis
Date:5/18/2010

ThalesNano and METTLER TOLEDO announced a collaboration to combine their existing technologies to offer flow reactor technology with real time reaction monitoring for faster reaction optimization and improved continuous process production.

(PRWEB) -- ThalesNano and METTLER TOLEDO announced a partnership to offer flow reactor technology with real-time reaction monitoring for faster reaction optimization and improved continuous process production. The customer-driven collaboration will result in the integration of ThalesNano’s entire flow reactor line with the METTLER TOLEDO ReactIR DS Micro Flow Cell system to take flow chemistry beyond where it is today.

The pairing of ThalesNano’s best in class flow reactor technology with the market leading reaction monitoring system, ReactIR, will allow chemists to observe what is happening in their reaction in real time and modify reaction parameters “on the fly” to improve yield or selectivity within minutes. The combined systems can also be applied to reactions where toxic/dangerous intermediates may be generated. Inline reaction monitoring can notify the user whether all the intermediate has been reacted to make these reactions safer for chemists.

The integrated system can also be applied to large scale synthesis: when integrated with the H-Cube Midi or H-Cube Maxi, process or production chemists may monitor catalyst activity during the reaction and change to a fresh catalyst bed when conversion drops below an acceptable level due to catalyst poisoning. This will ensure high purity product, avoiding the expense of unnecessary purification.

The strategic relationship allows the two market leading companies in this field to combine to support the further development of one of the fastest growing areas in chemistry: flow chemistry.

“We are very excited to work with METTLER TOLEDO, the world leader in the process monitoring field, to make this revolutionary hybrid technology available to both of our customer bases,” said Laszlo Urge, CEO of ThalesNano. “The two flow-based technologies are so complimentary that minimal integration efforts are needed to combine them, meaning that current ReactIR users or ThalesNano customers may take advantage of this new application with virtually no system downtime: ThalesNano customers can get immediate access to online analytics and METTLER TOLEDO customers are provided with an easy way to start exploiting the benefits of flow chemistry.”

“By focusing on providing a complete solution, the two companies will jointly identify and develop a robust, cost effective offering to meet the developing needs of our customers,” said Henry Dubina, Head of METTLER TOLEDO AutoChem “Continuous chemistry has emerged as an important tool in the development and manufacturing of chemical based processes. ReactIR, our in situ Fourier Transform Infrared Monitoring (FTIR) spectroscopy system, has been established as a critical technique to allow the scientist to quickly and accurately determine steady state dispersion characteristics, reactive intermediates, reaction initiation and identify process upsets. The combination of these two technologies should result in even higher yields, reduced purities and significant time and cost savings for our users.”

ThalesNano is the world leader in bench-top flow chemistry reactors. The company has the widest portfolio of bench top continuous process instruments for the pharmaceutical, biotech, fine chemical, petroleum/biofuel, and education markets. Its R&D 100 award winning H-Cube® and scale-up system H-Cube Midi™ are used in hundreds of laboratories globally and have become the new industry standard for hydrogenation. Within three years from the original introduction of its flagship H-Cube product, 20 out of the top 20 pharmaceutical companies have introduced and adopted the technology.

METTLER TOLEDO provides the enabling technology, software and people that can help build a seamless workflow to translate bench scale chemistry into a commercial process. For more than 20 years, our enabling tools and services have been a strategic resource providing critical information for thousands of development scientists and engineers. Companies have used that knowledge to accelerate the discovery, development and scale-up of new chemical processes spanning the chemical and biopharmaceutical industries.

###

Read the full story at http://www.prweb.com/releases/reaction/monitoring/prweb4011744.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Process Safety and Thermal Hazard Analysis Fall Webinar Series presented by METTLER TOLEDO
2. Maximize Data Analysis with METTLER TOLEDO FBRM
3. METTLER TOLEDO and AAPS: Utilization of Process Modeling and Advanced Process Control in QbD based Drug Development and Manufacturing
4. METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis (SPPS)
5. Martin Madaus Joins Mettler Toledo Board of Directors
6. Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies
7. ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India
8. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
9. Worlds Top 20 Pharmaceutical Companies Deploy Revolutionary H-Cube(R) From ThalesNano Inc.
10. World Leader in Bench-Top Flow Chemistry Instruments ThalesNano, Inc. Closes Funding Round
11. World Leader in Bench Top Flow Chemistry Instruments ThalesNano, Inc. Introduces an Industry First Seminar Series
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
METTLER TOLEDO and ThalesNano Bring Real-time Reaction Monitoring to Flow Synthesis 
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):